[Current and future drug therapies for smoking cessation].
Pérez Trullén
A
A
Profesor asociado de Medicina. Universidad de Zaragoza. Médico adjunto de Neumología. Hospital Universitario Lozano Blesa. Zaragoza.
Clemente Jiménez
M
M
D000279:Administration, Cutaneous; D000284:Administration, Oral; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002638:Chewing Gum; D002985:Clinical Protocols; D003000:Clonidine / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006801:Humans; D008120:Lobeline / Q000627:therapeutic use; D008464:Mecamylamine / Q000627:therapeutic use; D009330:Nebulizers and Vaporizers; D009538:Nicotine / Q000031:analogs & derivatives / Q000097:blood / Q000627:therapeutic use*; D018722:Nicotinic Agonists / Q000097:blood / Q000627:therapeutic use*; D018733:Nicotinic Antagonists / Q000627:therapeutic use*; D011109:Polymethacrylic Acids / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D012907:Smoking / Q000097:blood / Q000188:drug therapy*; D061485:Tobacco Use Cessation Devices
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D002638:Chewing Gum; D003692:Delayed-Action Preparations; D018722:Nicotinic Agonists; D018733:Nicotinic Antagonists; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D008464:Mecamylamine; D009538:Nicotine; D008120:Lobeline; D003000:Clonidine